{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"8"}],"title":"Using Opioid"},{"measurements":[{"groupId":"OG000","value":"135"},{"groupId":"OG001","value":"126"}],"title":"No Opioid Use"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"141"},{"groupId":"OG001","value":"134"}],"units":"Participants"}],"description":"at a given time divided by the total number of patients randomized to that group at Day 90) by review of medication records and urine drug test","groups":[{"description":"Acupuncture will start on Day 0 and continue once daily to Day 15, as long as the patient is inpatient or comes to the clinic for post-transplantation follow-up. to prevent severe pain. If acupuncture does not prevent severe pain, the participant will receive opioid medication as backup pain relief.\n\nAcupuncture: Acupuncture treatments will be scheduled to cover the period of high symptom burden. Acupuncture will start on Day 0 and continue once daily to Day 15, as long as the patient is inpatient or comes to the clinic for post-transplantation follow-up. Electrical stimulation (e-acupuncture) may be applied to the ST36 and SP6 points when appropriate as per standard acupuncture practice.\n\nopioid: All study patients will receive the usual HSCT care and pain management regimens (usually opioids) as per standard practice at the study institution.\n\nAssessments: Participants will be asked to complete patient reported outcomes assessments online using REDCap or, If they prefer, via pencil and paper or over the phone. Assessments at baseline (within 4 weeks before HiChemo) and on or about days 7, 15, 30, and 90 after the first dose of HiChemo.","id":"OG000","title":"Acupuncture Plus Usual Care"},{"description":"Will receive only the usual pain management approach, which includes opioid medication when needed for severe pain, according to the routine guidelines for their care.\n\nopioid: All study patients will receive the usual HSCT care and pain management regimens (usually opioids) as per standard practice at the study institution.\n\nAssessments: Participants will be asked to complete patient reported outcomes assessments online using REDCap or, If they prefer, via pencil and paper or over the phone. Assessments at baseline (within 4 weeks before HiChemo) and on or about days 7, 15, 30, and 90 after the first dose of HiChemo.","id":"OG001","title":"Usual Care"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"at day 90","title":"the Number of Patients Using Opioids at a Given Time","type":"PRIMARY","unitOfMeasure":"Participants"}